Abdulwahab Alamri

8PUBLICATIONS
35CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsGene and molecular therapyChild and adolescent developmentBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 24, 2023
Synthesis, Molecular Docking, and Dynamic Simulation Targeting Main Protease (Mpro) of New, Thiazole Clubbed Pyridine Scaffolds as Potential COVID-19 Inhibitors.

Adel Alghamdi, Amr S Abouzied, Abdulwahab Alamri

|Nov 26, 2022
Can Natural Products Targeting EMT Serve as the Future Anticancer Therapeutics?

Sirajudheen Anwar, Jonaid Ahmad Malik, Sakeel Ahmed

|Nov 20, 2022
Discovery of oxindole-based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation.

Onur Bender, Mai E Shoman, Taha F S Ali

|Nov 11, 2022
Development and Characterization of PEGDA Microneedles for Localized Drug Delivery of Gemcitabine to Treat Inflammatory Breast Cancer.

Ahmed Alafnan, Aravindram Attiguppe Seetharam, Talib Hussain

|Oct 27, 2022
Cucurbitacin-B Exerts Anticancer Effects through Instigation of Apoptosis and Cell Cycle Arrest within Human Prostate Cancer PC3 Cells via Downregulating JAK/STAT Signaling Cascade.

Ahmed Alafnan, Abdulwahab Alamri, Talib Hussain

|Oct 27, 2022
The Influence of Prenatal Exposure to Quetiapine Fumarate on the Development of Dopaminergic Neurons in the Ventral Midbrain of Mouse Embryos.

Walaa F Alsanie, Sherin Abdelrahman, Majid Alhomrani

Pageof 2

Frequent Collaborators

4 joint publications

Sirajudheen Anwar

2 joint publications

Nafees Ahemad

2 joint publications

Adel Alghamdi

2 joint publications

Syed Mohd Danish Rizvi